Ligand validation:7SXE

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 7SXE designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7SXE_AMP_A_1001	54%	40%	0.166	0.94	0.93	1.39	1	3	4	0	96%	0.9565
6P0C_AMP_C_101	99%	63%	0.051	0.983	0.51	0.9	-	-	0	0	100%	0.9565
9BS4_AMP_A_1001	97%	43%	0.053	0.969	0.85	1.36	-	2	0	0	100%	0.9565
9BS3_AMP_E_1001	87%	45%	0.077	0.95	0.83	1.27	-	2	0	0	100%	0.9565
7SUM_AMP_A_1001	86%	44%	0.102	0.978	0.9	1.27	1	2	0	0	96%	0.9565
6P0D_AMP_C_101	84%	43%	0.09	0.95	0.96	1.25	1	3	0	0	100%	0.9565
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
4RDH_AMP_C_301	100%	23%	0.039	0.983	1.37	1.79	3	6	0	0	100%	1
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1
5VEO_AMP_A_524	100%	40%	0.046	0.987	0.86	1.47	-	3	1	0	100%	1
3CLR_AMP_C_1262	100%	41%	0.048	0.989	1.01	1.29	1	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.